NanoSystems Biology Cancer Center 2
California Institute of Technology

Project 1: Organ-Specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain and Ovarian Cancers: Technologies for Rapid Evaluation, Validation, and Clinical Translation
Project 2: Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy
Project 3: Molecular Imaging of Metabolic Switches in Malignant Transformations
Project 4: Nanotechnologies for Assessing Molecular Heterogeneity and Therapeutic Resistance in GBM Patients
Project 5: RNA-Interference-Based Nanotherapeutics

Center Overview

Technologies developed by the California Institute of Technology CCNE provide a pathway for the early detection and informative diagnosis of melanoma, glioblastoma, and ovarian cancers through in vitro diagnostics and in vivo molecular imaging. Direct applications to targeted therapies, including molecularly targeted therapies, adoptive T cell immunotherapies and siRNA therapies are explored within this CCNE.